article

1. Outcome Measurement Instruments Used to Evaluate Dermatologic Adverse Events in Cancer Trials: A Systematic Review..  JAMA dermatology.  160:651-657. 2024
2. A Multicenter Retrospective Cohort Study to Characterize Patients Hospitalized With Multisystem Inflammatory Syndrome in Adults and Coronavirus Disease 2019 in the United States, 2020-2021..  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.  77:1395-1405. 2023
3. Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations..  The Journal of rheumatology.  50:433-437. 2022
4. Linear IgA bullous dermatosis in the setting of angioimmunoblastic T-cell lymphoma..  Journal of cutaneous pathology.  50:43-46. 2022
5. Hospital practices and clinical outcomes associated with behavioral symptoms in persons with dementia..  Journal of hospital medicine.  17:702-709. 2022
6. Age- and Sex- Adjusted Prevalence Estimates Among Pediatric Patients with Psoriasis in the United States..  The British journal of dermatology.  187:270-271. 2022
7. Mucocutaneous manifestations among adults hospitalized with multisystem inflammatory syndrome following SARS-CoV-2 infection..  JAAD international.  111-113. 2022
8. Prevalence of Marfan syndrome, Ehlers-Danlos syndrome, and osteogenesis imperfecta in patients with hidradenitis suppurativa..  Journal of the American Academy of Dermatology.  86:471-474. 2021
9. Adverse pregnancy and maternal outcomes in women with hidradenitis suppurativa..  Journal of the American Academy of Dermatology.  86:46-54. 2021
10. Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19..  Journal of the American Academy of Dermatology.  84:946-952. 2020
11. Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children..  Journal of the American Academy of Dermatology.  84:408-414. 2020
12. Association Between Hidradenitis Suppurativa and Lymphoma..  JAMA dermatology.  155:624-625. 2019
13. Overall and subgroup prevalence of pyoderma gangrenosum among patients with hidradenitis suppurativa: A population-based analysis in the United States..  Journal of the American Academy of Dermatology.  80:1533-1537. 2019